Menu Search
Equities

BioLargo Inc

BLGO:QXR

BioLargo Inc

Actions
  • Price (USD)0.1794
  • Today's Change-0.001 / -0.28%
  • Shares traded96.29k
  • 1 Year change+5.59%
  • Beta0.1859
Data delayed at least 15 minutes, as of Nov 22 2024 20:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year BioLargo Inc grew revenues 107.85% from 5.88m to 12.23m while net income improved from a loss of 4.47m to a smaller loss of 3.50m.
Gross margin44.30%
Net profit margin-19.65%
Operating margin-19.59%
Return on assets-43.15%
Return on equity-27.06%
Return on investment-40.94%
More ▼

Cash flow in USDView more

In 2023, BioLargo Inc increased its cash reserves by 91.19%, or 1.69m. Cash Flow from Financing totalled 4.66m or 38.09% of revenues. In addition the company used 2.37m for operations while cash used for investing totalled 478.00k.
Cash flow per share-0.0119
Price/Cash flow per share--
Book value per share0.0285
Tangible book value per share0.0285
More ▼

Balance sheet in USDView more

BioLargo Inc appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 3.54m.
Current ratio2.31
Quick ratio2.24
Total debt/total equity0.0443
Total debt/total capital0.0597
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.